跳转至内容
Merck
CN
  • Microarc oxidized TiO2 based ceramic coatings combined with cefazolin sodium/chitosan composited drug film on porous titanium for biomedical applications.

Microarc oxidized TiO2 based ceramic coatings combined with cefazolin sodium/chitosan composited drug film on porous titanium for biomedical applications.

Materials science & engineering. C, Materials for biological applications (2013-08-06)
Daqing Wei, Rui Zhou, Su cheng, Wei Feng, Baoqiang Li, Yaming Wang, Dechang Jia, Yu Zhou, Haifeng Guo
摘要

Porous titanium was prepared by pressureless sintering of titanium beads with diameters of 100, 200, 400 and 600 μm. The results indicated that the mechanical properties of porous titanium changed significantly with different bead diameters. Plastic deformations such as necking phenomenon and dimple structure were observed on the fracture surface of porous titanium sintered by beads with diameter of 100 μm. However, it was difficult to find this phenomenon on the porous titanium with a titanium bead diameter of 600 μm. The microarc oxidized coatings were deposited on its surface to improve the bioactivity of porous titanium. Furthermore, the cefazolin sodium/chitosan composited films were fabricated on the microarc oxidized coatings for overcoming the inflammation due to implantation, showing good slow-release ability by addition of chitosan. And the release kinetic process of cefazolin sodium in composited films could be possibly fitted by a polynomial model.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
氧化钛(IV), nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
Sigma-Aldrich
氧化钛 (IV),锐钛矿, nanopowder, <25 nm particle size, 99.7% trace metals basis
Sigma-Aldrich
氧化钛 (IV),锐钛矿, powder, 99.8% trace metals basis
Sigma-Aldrich
氧化钛(IV), ReagentPlus®, ≥99%
Sigma-Aldrich
氧化钛 (IV),锐钛矿, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
氧化钛(IV), puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5%
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, powder, <5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, nanopowder, <100 nm particle size, 99.5% trace metals basis
Sigma-Aldrich
氧化钛(IV),金红石和锐钛矿混合物, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
Sigma-Aldrich
头孢唑啉 钠盐, 89.1-110.1%
Sigma-Aldrich
氧化钛(IV),金红石和锐钛矿混合物, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, ≥99.98% trace metals basis
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, 99.995% trace metals basis
Sigma-Aldrich
氧化钛(IV), contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
USP
头孢唑啉, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, <001>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
头孢唑啉, European Pharmacopoeia (EP) Reference Standard